We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$721M
AUM Growth
+$3.8M
Cap. Flow
-$22.4M
Cap. Flow %
-3.1%
Top 10 Hldgs %
29.13%
Holding
154
New
13
Increased
38
Reduced
45
Closed
15

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$6.22M
2
COR icon
Cencora
COR
+$5.63M
3
ILMN icon
Illumina
ILMN
+$5.46M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.98M
5
PRGO icon
Perrigo
PRGO
+$4.77M

Top Sells

Rank Stock Value
1
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$18.9M
2
BAX icon
Baxter International
BAX
+$9.56M
3
CNC icon
Centene
CNC
+$8.47M
4
LCI
Lannett Company, Inc.
LCI
+$6.61M
5
MOH icon
Molina Healthcare
MOH
+$6.39M

Sector Composition

Rank Sector Weight
1 Healthcare 90.06%
2 Financials 0.8%
3 Industrials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSII
126
DELISTED
Cardiovascular Systems, Inc.
CSII
$529K 0.07%
+20,000
New +$646K
ENTL
127
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$517K 0.07%
20,000
-10,000
-33% -$253K
RLYP
128
DELISTED
RELYPSA INC COM
RLYP
$496K 0.07%
15,000
-40,000
-73% -$1.38M
EXEL icon
129
Exelixis
EXEL
$13.1B
$376K 0.05%
100,000
-200,000
-67% -$650K
GI
130
DELISTED
EndoChoice Holdings, Inc.
GI
$361K 0.05%
+22,056
New +$367K
PBYI icon
131
Puma Biotechnology
PBYI
$442M
$350K 0.05%
3,000
– –
PRXL
132
DELISTED
Parexel International Corp
PRXL
$322K 0.04%
5,000
– –
WMGI
133
DELISTED
Wright Medical Group Inc
WMGI
$263K 0.04%
+10,000
New +$264K
CERS icon
134
Cerus
CERS
$508M
$241K 0.03%
46,520
-53,480
-53% -$253K
GERN icon
135
Geron
GERN
$949M
$193K 0.03%
45,000
– –
TBPH icon
136
Theravance Biopharma
TBPH
$876M
$149K 0.02%
11,428
-16,463
-59% -$255K
EIGR
137
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$95K 0.01%
+167
New +$462K
AST
138
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$9K ﹤0.01%
1,875
– –
BTX.WS
139
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$3K ﹤0.01%
2,294
– –
ASRT
140
DELISTED
Assertio
ASRT
– –
-908
Closed -$1.22M
BAX icon
141
Baxter International
BAX
$14.4B
– –
-256,820
Closed -$9.56M
BIS icon
142
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.06M
– –
-9,375
Closed -$2.59M
BKD icon
143
Brookdale Senior Living
BKD
$3.27B
– –
-134,140
Closed -$5.07M
IBB icon
144
iShares Biotechnology ETF
IBB
$9.82B
– –
-18,000
Closed -$2.06M
MOH icon
145
Molina Healthcare
MOH
$10.4B
– –
-94,960
Closed -$6.39M
OEF icon
146
PUT
iShares S&P 100 ETF
OEF
$20.5B
– –
-100
Closed -$161K
STE icon
147
Steris
STE
$23.3B
– –
-27,000
Closed -$1.9M
LCI
148
DELISTED
Lannett Company, Inc.
LCI
– –
-24,388
Closed -$6.61M
MDCO
149
DELISTED
Medicines Co
MDCO
– –
-70,000
Closed -$1.96M
SGNT
150
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-100,000
Closed -$2.33M
3 4 5
6
7

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.57% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q2 2015 Portfolio in Review

As of Q2 2015, Bellevue Asset Management (Switzerland) held 154 positions worth $721M, up 0.53% from $717M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Asset Management (Switzerland) withdrew a net $22.4M in Q2 2015, closing 15 positions and reducing 45 holdings. Its most notable exit was CATAMARAN CORP COM STK (CDA), an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 85% a quarter earlier, followed by Financials and Industrials.

Against the trend, Bellevue Asset Management (Switzerland) opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $5.21M.

  • Bellevue Asset Management (Switzerland)'s largest Q2 2015 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 150,000 shares worth $5.21M.
  • Bellevue Asset Management (Switzerland) added most to Endo International plc in Q2 2015, an estimated $6.22M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q2 2015 reduction was Centene, cutting an estimated $8.47M.
  • Bellevue Asset Management (Switzerland) fully exited CATAMARAN CORP COM STK (CDA) in Q2 2015, selling an estimated $18.9M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 29% of its $721M portfolio in Q2 2015.
  • Bellevue Asset Management (Switzerland) opened 13 new positions and closed 15 in Q2 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 0.53% quarter-over-quarter to $721M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q2 2015, filed 12 Aug 2015.